v3.24.1
Stockholders' Equity (Tables)
 12 Months Ended
Feb. 04, 2024
Equity [Abstract]  
Summary of Significant Assumptions Used in Determining Underlying Fair Value of Weighted-Average Options Granted
A summary of the options, as well as the significant assumptions used in determining the underlying fair value of those options, granted in fiscal 2023 were as follows:
VolatilityRisk-free Interest RateExpected Term
(in years)		Weighted Average Grant Date
Fair Value		Options Granted
April 2023 time-based grant (1)
66.3%3.5%6.7$22.27 0.07 
Other 2023 time-based grants (2)
67.2%3.9%7.3$21.97 0.01 
Total granted0.08 
(1)Annual grant to certain executives.
(2)Grants to newly hired executive employees.
Summary of Transactions Related to Stock Options Awards
The following is a summary of stock option award activity during fiscal 2023:
Number
of Options 		Weighted
Average
Exercise
Price
Outstanding at January 29, 20230.98 $40.64 
Granted0.08 35.09 
Exercised(0.12)32.81 
Forfeited and cancelled(0.12)36.74 
Outstanding at February 4, 20240.82 42.96 
Exercisable at February 4, 20240.48 $47.92 
Summary of Transactions Related to Restricted Stock Units
The following is a summary of restricted stock unit awards activity during fiscal 2023:
Shares Weighted
Avg
Grant Date
Fair Value
Outstanding at January 29, 20231.89$31.02 
Granted0.2835.94 
Vested(0.29)25.61 
Forfeited(0.37)30.92 
Outstanding at February 4, 20241.51$33.65 
Schedule of Stock Options Roll Forward
Compensation expense related to stock option plans and time-based restricted stock units, which is included in general and administrative expenses on the consolidated statements of comprehensive income, was as follows for the fiscal years presented:
202320222021
Stock options$2.7 $2.5 $0.5 
Restricted stock units13.3 17.5 12.0 
Total compensation expense$16.0 $20.0 $12.5